Last reviewed · How we verify
NTM-1634
At a glance
| Generic name | NTM-1634 |
|---|---|
| Sponsor | Alachua Government Services, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NTM-1634 CI brief — competitive landscape report
- NTM-1634 updates RSS · CI watch RSS
- Alachua Government Services, Inc. portfolio CI